Evidence map

TrialHypertension research : official journal of the Japanese Society of Hypertension2020

Luseogliflozin, a sodium-glucose cotransporter 2 inhibitor, preserves renal function irrespective of acute changes in the estimated glomerular filtration rate in Japanese patients with type 2 diabetes.

Kentaro Kohagura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32203453